ArticleFrontiers in pharmacology2017

E-M, an Engineered Endostatin with High ATPase Activity, Inhibits the Recruitment and Alternative Activation of Macrophages in Non-small Cell Lung Cancer.

Min Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.